Filing Details

Accession Number:
0001209191-13-039262
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-05 18:18:26
Reporting Period:
2013-08-02
Filing Date:
2013-08-05
Accepted Time:
2013-08-05 17:18:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1254419 Medassets Inc MDAS Services-Prepackaged Software (7372) 510391128
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1415808 J Terrence Mulligan 100 North Point Center East
Suite 200
Alpharetta GA 30022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-02 11,668 $9.68 143,819 No 4 M Indirect By Terrence J. Mulligan Living Trust
Common Stock Acquisiton 2013-08-02 17,778 $9.29 161,597 No 4 M Indirect By Terrence J. Mulligan Living Trust
Common Stock Disposition 2013-08-02 29,446 $23.39 132,151 No 4 S Indirect By Terrence J. Mulligan Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Terrence J. Mulligan Living Trust
No 4 M Indirect By Terrence J. Mulligan Living Trust
No 4 S Indirect By Terrence J. Mulligan Living Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2013-08-02 11,668 $0.00 11,668 $9.68
Common Stock Stock Options (Right to Buy) Disposition 2013-08-02 17,778 $0.00 17,778 $9.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-10-05 No 4 M Direct
0 2017-09-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Restricted Stock 5,168 Direct
Restricted Stock 776 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $15.95 2018-03-25 5,242 5,242 Direct
Common Stock Stock-Settled Stock Appreciation Rights $12.98 2016-01-15 20,347 20,347 Direct
Common Stock Stock-Settled Stock Appreciation Rights $21.27 2017-01-15 18,982 18,982 Direct
Common Stock Stock-Settled Stock Appreciation Rights $16.04 2018-05-09 18,242 18,242 Direct
Common Stock Stock-Settled Stock Appreciation Rights $16.04 2018-05-09 2,488 2,488 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-03-25 5,242 5,242 Direct
2016-01-15 20,347 20,347 Direct
2017-01-15 18,982 18,982 Direct
2018-05-09 18,242 18,242 Direct
2018-05-09 2,488 2,488 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.32 to $23.40, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  2. The reporting person was granted 5,168 restricted shares on February 25, 2013. The shares vest 1/4 beginning on March 1, 2013 and equally thereafter such that 100% of the shares will be fully vested on December 1, 2013.
  3. The reporting person was granted 776 restricted shares on February 25, 2013. The shares vest 1/4 beginning on March 1, 2013 and equally thereafter such that 100% of the shares will be fully vested on December 1, 2013.
  4. The reporting person was granted these stock options on October 5, 2006 and are fully vested.
  5. The reporting person was granted these stock options on September 10, 2007 and are fully vested.
  6. The reporting person was granted these stock options on March 25, 2008 and are fully vested.
  7. The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 15, 2009 and are fully vested.
  8. The reporting person was granted these SSARs on January 15, 2010 and are fully vested.
  9. The reporting person was granted these SSARs on May 9, 2011 and are fully vested.